Free Trial
The Rate Lock Ends Tonight! MarketBeat All Access Returns to $249
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Save $100 a Year
Claim MarketBeat All Access Sale Promotion

Quantinuum (NASDAQ:QNT) Reaches New 52-Week Low - Here's What Happened

Quantinuum logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Quantinuum shares fell 11.1%, reaching a new 52-week low of $32.91 and closing near $33.21, well below the 50-day moving average of $45.96.
  • The company reported quarterly revenue of $8 million and an adjusted loss of $0.28 per share, missing analysts’ expected loss of $0.26; analysts forecast a full-year loss of $4.76 per share.
  • Despite the sell-off, analyst sentiment remains a “Moderate Buy”, with an average price target of $94.23, while several major hedge funds recently established or increased positions in the company.
  • MarketBeat previews top five stocks to own in November.

Shares of Quantinuum Inc. (NASDAQ:QNT - Get Free Report) hit a new 52-week low during mid-day trading on Friday. The stock traded as low as $32.91 and last traded at $33.21, with a volume of 2,008,151 shares. The stock had previously closed at $37.49.

Analysts Set New Price Targets

QNT has been the topic of a number of research analyst reports. Weiss Ratings started coverage on shares of Quantinuum in a research note on Monday, August 31st. They set a "sell (d)" rating on the stock. Wall Street Zen downgraded shares of Quantinuum from a "hold" rating to a "sell" rating in a report on Saturday, July 4th. Cantor Fitzgerald restated an "overweight" rating and issued a $90.00 price target on shares of Quantinuum in a research report on Wednesday, August 12th. Yorkville Ives began coverage on Quantinuum in a research note on Monday, October 5th. They issued an "outperform" rating and a $60.00 target price on the stock. Finally, Rosenblatt Securities reissued a "buy" rating and set a $155.00 price objective on shares of Quantinuum in a report on Thursday, October 22nd. Thirteen analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Quantinuum presently has an average rating of "Moderate Buy" and an average target price of $94.23.

Check Out Our Latest Report on QNT

Quantinuum Trading Down 11.1%

The stock has a market capitalization of $8.78 billion and a P/E ratio of -119.07. The company's fifty day simple moving average is $45.96.

Quantinuum (NASDAQ:QNT - Get Free Report) last issued its quarterly earnings results on Tuesday, August 11th. The company reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.26) by ($0.02). The company had revenue of $8.00 million during the quarter. Sell-side analysts predict that Quantinuum Inc. will post -4.76 EPS for the current fiscal year.

Hedge Funds Weigh In On Quantinuum

Several large investors have recently modified their holdings of the business. Wellington Management Group LLP acquired a new stake in Quantinuum during the second quarter worth approximately $92,418,000. HBK Investments L P bought a new position in Quantinuum during the second quarter valued at $14,669,000. BlueCrest Capital Management Ltd purchased a new position in shares of Quantinuum in the second quarter worth about $14,304,000. McGuire Investment Group LLC boosted its stake in Quantinuum by 1,892.4% in the 3rd quarter. McGuire Investment Group LLC now owns 57,360 shares of the company's stock worth $2,757,000 after purchasing an additional 54,481 shares during the period. Finally, Readystate Asset Management LP purchased a new stake in Quantinuum in the 2nd quarter worth approximately $4,111,000.

Quantinuum Company Profile

(Get Free Report)

Quantinuum is a quantum computing company formed in 2021 through the combination of Honeywell Quantum Solutions and Cambridge Quantum. The company develops full-stack quantum computing technologies designed to support research and commercial applications across industries, including chemistry, materials science, cybersecurity, finance and artificial intelligence.

Its offerings include trapped-ion quantum computers, quantum software and development tools. Quantinuum's software portfolio includes the TKET quantum compiler, InQuanto quantum chemistry platform, Quantum Origin quantum-enhanced cybersecurity solutions and the Nexus platform for developing and managing quantum applications.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Quantinuum Right Now?

Before you consider Quantinuum, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quantinuum wasn't on the list.

While Quantinuum currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines